A detailed history of Wellington Management Group LLP transactions in Verona Pharma PLC stock. As of the latest transaction made, Wellington Management Group LLP holds 1,878,632 shares of VRNA stock, worth $67 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,878,632
Previous 1,571,360 19.55%
Holding current value
$67 Million
Previous $22.7 Million 137.88%
% of portfolio
0.01%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.46 - $30.16 $4.75 Million - $9.27 Million
307,272 Added 19.55%
1,878,632 $54 Million
Q2 2024

Aug 13, 2024

SELL
$11.48 - $17.02 $26.8 Million - $39.8 Million
-2,338,106 Reduced 59.81%
1,571,360 $22.7 Million
Q1 2024

May 15, 2024

BUY
$15.3 - $20.24 $59.8 Million - $79.1 Million
3,909,466 New
3,909,466 $62.9 Million
Q4 2023

Feb 12, 2024

BUY
$11.94 - $20.47 $45.2 Million - $77.5 Million
3,783,994 New
3,783,994 $75.2 Million
Q3 2023

Nov 14, 2023

BUY
$16.3 - $22.09 $2.68 Million - $3.63 Million
164,268 Added 3.82%
4,467,571 $72.8 Million
Q2 2023

Aug 14, 2023

BUY
$19.41 - $23.43 $19.6 Million - $23.7 Million
1,011,830 Added 30.74%
4,303,303 $91 Million
Q1 2023

May 12, 2023

SELL
$18.06 - $25.27 $991,439 - $1.39 Million
-54,897 Reduced 1.64%
3,291,473 $66.1 Million
Q4 2022

Feb 13, 2023

SELL
$9.84 - $26.13 $8.18 Million - $21.7 Million
-830,906 Reduced 19.89%
3,346,370 $87.4 Million
Q3 2022

Nov 14, 2022

BUY
$4.14 - $13.59 $1.45 Million - $4.74 Million
349,127 Added 9.12%
4,177,276 $42.7 Million
Q2 2022

Aug 15, 2022

BUY
$3.55 - $5.06 $175,242 - $249,781
49,364 Added 1.31%
3,828,149 $16 Million
Q1 2022

May 16, 2022

SELL
$4.82 - $6.98 $5.08 Million - $7.35 Million
-1,053,203 Reduced 21.8%
3,778,785 $18.9 Million
Q4 2021

Feb 11, 2022

BUY
$3.91 - $7.08 $2.1 Million - $3.81 Million
537,950 Added 12.53%
4,831,988 $32.5 Million
Q3 2021

Nov 15, 2021

BUY
$5.29 - $6.35 $2.02 Million - $2.43 Million
382,198 Added 9.77%
4,294,038 $23.5 Million
Q2 2021

Aug 16, 2021

BUY
$5.72 - $9.09 $650,358 - $1.03 Million
113,699 Added 2.99%
3,911,840 $25.6 Million
Q1 2021

May 17, 2021

BUY
$7.08 - $9.33 $18.1 Million - $23.8 Million
2,552,442 Added 204.9%
3,798,141 $31.8 Million
Q4 2020

Feb 12, 2021

BUY
$5.51 - $8.11 $6.86 Million - $10.1 Million
1,245,699 New
1,245,699 $8.72 Million

Others Institutions Holding VRNA

About Verona Pharma plc


  • Ticker VRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,954,200
  • Market Cap $2.17B
  • Description
  • Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...
More about VRNA
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.